WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals Ltd Stock Ownership - Who owns Kiniksa Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Kiniksa Pharmaceuticals Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael R. MegnaCHIEF ACCOUNTING OFFICER2024-04-081,666$17.90
$29.82kSell
Sanj K. PatelCHAIRMAN CEO2024-04-084,075$17.90
$72.94kSell
Ross MoatCHIEF COMMERCIAL OFFICER2024-04-081,353$17.90
$24.22kSell
Eben TessariCHIEF OPERATING OFFICER2024-04-08801$17.90
$14.34kSell
John F. PaoliniCHIEF MEDICAL OFFICER2024-04-08733$17.90
$13.12kSell
Mark RagosaCHIEF FINANCIAL OFFICER2024-04-08791$17.90
$14.16kSell
John F. PaoliniCHIEF MEDICAL OFFICER2024-04-01477$19.70
$9.40kSell
Mark RagosaCHIEF FINANCIAL OFFICER2024-04-01514$19.70
$10.13kSell
Michael R. MegnaCHIEF ACCOUNTING OFFICER2024-04-011,084$19.70
$21.35kSell
Sanj K. PatelCHAIRMAN CEO2024-04-011,903$19.70
$37.49kSell

1 of 7

KNSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KNSA insiders and whales buy or sell their stock.

KNSA Shareholders

What type of owners hold Kiniksa Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc4.50%3,180,588$53.69MInstitution
Vanguard Group Inc4.20%2,965,299$50.05MInstitution
Rubric Capital Management LP4.12%2,907,501$49.08MInstitution
Fairmount Funds Management LLC4.08%2,883,221$48.67MInstitution
Baker Bros Advisors LP3.98%2,809,577$47.43MInstitution
Baker Bros Advisors LP3.87%2,734,183$46.15MInsider
Cormorant Asset Management LP2.45%1,731,442$29.23MInsider
Morgan Stanley2.26%1,595,479$26.93MInstitution
Pictet Asset Management Holding Sa2.22%1,570,816$26.52MInstitution
State Street Corp2.19%1,546,096$26.10MInstitution

1 of 3

KNSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KNSA48.48%9.87%Net SellingNet Selling
AUTL43.49%0.00%
SYRE55.87%44.13%Net BuyingNet Buying
SLNO20.62%79.38%Net BuyingNet Selling
AKRO66.82%33.18%Net BuyingNet Buying
View Top Biotech Stocks

Kiniksa Pharmaceuticals Stock Ownership FAQ

Who owns Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals (NASDAQ: KNSA) is owned by 48.48% institutional shareholders, 9.87% Kiniksa Pharmaceuticals insiders, and 41.65% retail investors. Baker Bros Advisors LP is the largest individual Kiniksa Pharmaceuticals shareholder, owning 2.73M shares representing 3.87% of the company. Baker Bros Advisors LP's Kiniksa Pharmaceuticals shares are currently valued at $46.24M.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.